RIPE-KG · Version 1.1.0 · Resource
ripekg:work/10.1016%2Fs2666-5247%2823%2900216-1
https://w3id.org/ripe/ripe-kg/work/10.1016%2Fs2666-5247%2823%2900216-1
| Subject | Predicate | Object |
|---|---|---|
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis |
http://purl.org/spar/cito/cites |
ripekg:work/10.1016%2Fs2666-5247%2823%2900216-1Comparative antibody and cell-mediated immune responses, reactogenicity, and efficacy of homologous and heterologous boosting with CoronaVac and BNT162b2 (Cobovax): an open-label, randomised trial |
ripekg:work/10.1016%2Fs2666-5247%2823%2900216-1Comparative antibody and cell-mediated immune responses, reactogenicity, and efficacy of homologous and heterologous boosting with CoronaVac and BNT162b2 (Cobovax): an open-label, randomised trial |
prism:doi |
10.1016/s2666-5247(23)00216-1 |
ripekg:work/10.1016%2Fs2666-5247%2823%2900216-1Comparative antibody and cell-mediated immune responses, reactogenicity, and efficacy of homologous and heterologous boosting with CoronaVac and BNT162b2 (Cobovax): an open-label, randomised trial |
dcterms:title |
Comparative antibody and cell-mediated immune responses, reactogenicity, and efficacy of homologous and heterologous boosting with CoronaVac and BNT162b2 (Cobovax): an open-label, randomised trial |
ripekg:work/10.1016%2Fs2666-5247%2823%2900216-1Comparative antibody and cell-mediated immune responses, reactogenicity, and efficacy of homologous and heterologous boosting with CoronaVac and BNT162b2 (Cobovax): an open-label, randomised trial |
rdf:type |
node1 |
ripekg:work/10.1016%2Fs2666-5247%2823%2900216-1Comparative antibody and cell-mediated immune responses, reactogenicity, and efficacy of homologous and heterologous boosting with CoronaVac and BNT162b2 (Cobovax): an open-label, randomised trial |
rdf:type |
http://purl.org/spar/fabio/Work |
ripekg:work/10.1016%2Fs2666-5247%2823%2900216-1Comparative antibody and cell-mediated immune responses, reactogenicity, and efficacy of homologous and heterologous boosting with CoronaVac and BNT162b2 (Cobovax): an open-label, randomised trial |
rdf:type |
rdfs:Resource |
ripekg:work/10.1016%2Fs2666-5247%2823%2900216-1Comparative antibody and cell-mediated immune responses, reactogenicity, and efficacy of homologous and heterologous boosting with CoronaVac and BNT162b2 (Cobovax): an open-label, randomised trial |
rdf:type |
owl:Thing |
ripekg:work/10.1016%2Fs2666-5247%2823%2900216-1Comparative antibody and cell-mediated immune responses, reactogenicity, and efficacy of homologous and heterologous boosting with CoronaVac and BNT162b2 (Cobovax): an open-label, randomised trial |
rdf:type |
prov:Entity |
ripekg:work/10.1016%2Fs2666-5247%2823%2900216-1Comparative antibody and cell-mediated immune responses, reactogenicity, and efficacy of homologous and heterologous boosting with CoronaVac and BNT162b2 (Cobovax): an open-label, randomised trial |
rdf:type |
ripe:WorkWork |
ripekg:work/10.1016%2Fs2666-5247%2823%2900216-1Comparative antibody and cell-mediated immune responses, reactogenicity, and efficacy of homologous and heterologous boosting with CoronaVac and BNT162b2 (Cobovax): an open-label, randomised trial |
owl:sameAs |
https://semopenalex.org/work/W4385568795 |